• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The present invention relates to a method; said method comprising collecting data by questioning a subject about personality and / or health traits; and / or - performing one or more social and / or (bio) physical learning tests by and on said subject; characterized in that said data is used in a set of mathematical models, thereby assigning one or more Rating Factors to said subject, whereby said Rating Factor is a measure of said subject's propensity to respond to a painful stimulus or a painful stimulus. therapeutic strategy; and / or a measure of the intensity of said response from said subject.
    公开号:BE1023314B1
    申请号:E2015/5505
    申请日:2015-08-07
    公开日:2017-02-01
    发明作者:Alvaro Pereira；Dominique Demolle；Chantal Gossuin；Thibault Helleputte；Denis Gossen
    申请人:Tools 4 Patient SA；
    IPC主号:
    专利说明:

    Method and tools for predicting the response to pain in a subject
    TECHNICAL FIELD The invention relates to the technical field of the management and treatment of pain. In particular, it relates to a methodology and a tool for predicting the response to pain in a subject.
    BACKGROUND
    Pain is a unique brain response to a complex interaction between physiological phenomena and emotional and cognitive responses and is, thus, specific to the subject.
    Physiological effects depend on a variety of factors related to the origin of the pain such as metabolic factors (eg diabetes), toxic (eg chemotherapies or antiviral treatments), traumatic, surgical, neoplastic or infectious (eg shingles). ) and physiological. The physiological components of pain consist mainly of three dimensions: nociceptive pain, neuropathic pain, and inflammatory pain. These are well known in the field. Pain may be classified according to the origin of the lesion whether it is in the peripheral nervous system and / or the central nervous system.
    Today, pain management, especially in cancer strategies and approaches, is based on both the clinician's "best" approaches based on clinical practice and experience and the general guidelines / recommendations established by leaders. opinions and adopted by actors of the Health Policy. These recommendations are mainly the result of a balance between observations and expectations of pain relief in a patient population. As a result, caregivers most often stick to these population-based protocols and / or treatment recommendations.
    For pain in cancer, for example, conventional pain management is based on the use of specific analgesics, prescribed according to a pre-established protocol for drug administration. The management of pain in cancer begins with the patient's administration of mild analgesia (analgesics, painkillers) and ends with powerful morphine-like medications. Adjuvant analgesics may also be used.
    For focal neuropathic pain, conventional pain management is based on the use of lidocaine, antidepressant and antiepileptic compounds and, secondarily, cutaneous patches of capsaicin, tramadol and opioids.
    For perioperative pain management, conventional pain management by the anesthetist is based on the use of options such as epidural or intrathecal opioids, patient-controlled systemic opioid analgesia, or regional techniques. including, as far as possible, NSAID, COXIB, or acetaminophen treatment in uninterrupted dosage or by regional inhibition with local anesthetics.
    Although for each of these different areas of pain, a specific treatment or recommended protocol may be possible, the results and success rate are often variable and disappointing. The low success rate can be attributed to various factors.
    Low success rates can result from poor patient compliance with recommended pain management protocols commonly used in medical practice to relieve pain. To address this problem, documents describe Clinical Decision Support Systems (CDSS) to correct pain management guidelines and increase adherence to these guidelines (Bertsche et al., Pain, 2009, 147: 20-28). Nevertheless, the CDSS proposed in this document is not intended to describe a subject's response to a painful stimulus or pain management treatment or strategy; rather, it aims to increase adherence to population-based pain management recommendations that are, however, not necessarily the most appropriate treatment for relieving painful symptoms in a particular subject. The low success rates may thus also be the result of the observation that drugs and the protocols using them (including the sequence of administration) are most often common to each patient to treat a disease or condition inducing pain. For these classical approaches the nature of the patient's specific pain has not been taken into account. On the contrary, these strategies have been proposed from data and observations collected at the level of a patient population. Low success rates may also be the result of a low level of knowledge about the general mechanisms that explain the onset and course of pain. Pain is a complex result of the interaction of a variety of factors including elements of nociceptive, neuropathic and inflammatory mechanisms. These mechanisms are not only complex in nature but their impact on the expression of pain by a subject differs from one subject to another.
    In addition, changes in the somatosensory system of subjects subjected to pain stimuli and / or pain treatment, both peripherally and centrally, may also result in misleading or difficult interpretations of efficacy. treatment or predicting a response to the patient's specific pain. Low rates of success may also be the result of changes over time in a subject's response to a painful stimulus or pain treatment.
    It has thus been progressively recognized that one of the main reasons for disappointing results in pain management stems from the observation that the pain and pain treatment response is patient-specific, time-dependent and is specific to the disease. Unfortunately, to date there is no known way to define not only an accurate picture of the pain response at the subject / patient level but also to predict these patient specific reactions and their evolution over time.
    Therefore, there is also a need to design personalized pain relief treatments that specifically adapt to the characteristics of the subject as to his propensity to respond favorably to pain relief treatments.
    Secondarily, there is also a need for better pain management strategies whereby such strategies are based on appropriate multi-modular treatments including drug and non-drug treatments. Such treatments should be personalized according to a patient's response to pain and pain management.
    Better diagnostic and pain management strategies are needed nowadays because of the low rate of reliable methodologies and tools for pain assessment that incorporate the specific aspects of both subjects and mechanisms. pain.
    Few methodologies are proposed to elucidate the mechanisms of pain. US 2003 0 233 053 discloses a method in which information about a patient having felt pain or other sensation is collected to determine one or more mechanisms that can be inferred from the information. US 2003 0 233 053 is thus directed to decipher the mechanisms associated with the symptoms and to solve the problem of correctly identifying the mechanisms of pain underlying the expression of pain by a subject.
    There are documents that describe the assessment of the threshold of pain and which is based on the activation of biophysical stimuli. As an example, WO 2006 039 416 discloses a therapeutic efficacy prediction test for neuropathic pain. The method measures the activation threshold of pain by functional magnetic resonance imaging or other imaging methodologies.
    Methods exist that propose to adapt pain treatments to specific needs, most often based on a specific analysis of a single given factor, considered as a reliable measure of the evolution of pain in a subject. As an example, WO 2013 082 308 describes a method of personalized management of pain by evaluating the presence or absence of a genetic determinant (SNP mono-nucleotide polymorphism) in a subject. The method exclusively targets the presence / absence of the determinant and fails to take into account any other determining factor. US 2013 0 217 976 discloses an algorithm for assessing the ability of a subject to develop pain after surgery, such as hernia operation. The risk assessment is based solely on the patient's history and physical examination. WO 2014 059 278 discloses a methodology for learning a subject to accurately report pain in order to improve the accuracy of a clinical trial on pain management or to determine a treatment of pain. WO 2014 059 278 does not disclose a method for defining a profile of a patient's pain with respect to his pain response. None of the methodologies mentioned above take into account the multifactorial nature of pain, which depends largely on the specific patient.
    As previously explained, attempts have been made to improve patients' pain management both through recommendations or by proposing population-based treatment protocols and by developing and applying decision-support tools for patients. increase adherence to these recommendations. But approaches fail to materialize treatments because of the lack of reliable and multifactorial basis for such an objectified approach.
    As an attempt to solve the problem, US 5,908,383 discloses a computer processing method for producing a pain management treatment plan whereby said plan comprises patient responses to questions entered into a computer program as well. as demographic information, which allows you to calculate a personalized treatment plan. The method is targeted only at patients already suffering from pain, and can not be extended to healthy subjects or provide predictive insight into subjects, regardless of whether or not they suffer from pain. The method of US '383 does not predict the emission of a response to a painful stimulus. Thus, the method as described in US 5,908,383 rather provides a simple static picture of the patient's pain, not a dynamic image. In addition, the method of US 5,908,383 is built around expert data and decision trees, and is therefore not objective in its evaluation.
    There remains a need in the field for improved methodologies and algorithms to adequately predict the development of a pain response in a subject, and, therefore, (i) to better predict the response of a subject to a subject. pain stimulus or treatment or pain management strategy and (ii) improve the treatment of a patient's pain.
    There is a need to develop methods and tools for profiling a subject (signature, fingerprint) that qualifies and quantifies the propensity to respond to a painful stimulus or a favorable response to pain management treatment.
    SUMMARY OF THE INVENTION
    The present invention provides a method according to claim 1. The invention proposes to assign one or more Notation Factors to said subject whereby said Notation Factor is a measure of the propensity of a subject to issue a response to a treatment. management of pain or painful stimulus. The method has the advantage of combining (self) pain assessment and biophysical or somatosensory tests to produce a patient-specific pain profile, an approach that has not yet been used. The method is not a burden to the patient, and can therefore be performed more than once during a defined period, in order to satisfactorily control the progression or predict the evolution of the pain profiles. This is opposed to the methods currently used in the field.
    The profile is understood to be used in conjunction with various models, in order to serve the purpose of several applications. As such, the method can be used to predict the likelihood of a subject's response to a painful stimulus of claim 7 and to develop new treatments or to optimize existing pain relief therapies according to claim 8. Said method is preferably implemented by computer. Thus, the present invention also relates to a computer processing product according to claim 6. Finally, the present invention also relates to a diagnostic complementary tool according to claim 12, which can be used in addition to existing treatments, for the implementation of place of a clinical trial, etc.
    DESCRIPTION OF THE FIGURES
    Figure 1 shows a schematic overview of an embodiment of the methodology according to the present invention.
    Figure 2 is a screen shot of a computer interface according to an embodiment of the present invention, wherein scoring factors related to a pain profile are calculated based on the characteristics entered.
    DETAILED DESCRIPTION OF THE INVENTION
    The present invention relates to a method for establishing one or more Notation Factor (s) for a subject that can be used for various purposes in the field of pain management and treatment. The present invention aims to provide a holistic methodology, taking into account all relevant aspects that play a role in a subject's perception of pain.
    Unless otherwise defined, all the terms used in the disclosure of the invention, including technical and scientific terms, have the meaning commonly understood by the professional of the field to which this invention belongs. With additional guidance, definitions of terms are introduced to better appreciate the teaching of the present invention.
    As used herein, the following terms have the following meanings: "From", "a" and "the" as used herein refer to both the singular and the plural unless the context clearly justifies it. Using an example, "a bucket" refers to one or more compartments. "Approximate" as used herein with reference to a measurable value such as a parameter, quantity, duration, and the like means to include variations of +/- 20% or less, preferably +/- 10% or less more preferably +/- 5% or less, more preferably +/- 1% or less, and more preferably +/- 0.1% or less of and from the specified value, to the extent that such variations are appropriate to carry out the disclosed invention. However, it must be understood that the value to which the moderator "about" refers is itself also revealed in a specific way. "Understand", "understand", and "understand" and "understand" as used herein are synonymous with "include", "include", "include" or "contain", "contains", "contains" and are global terms or specific open to the presence of the following for example a component without excluding or excluding the presence of components, features, elements, members, additional steps, not listed, known in the field or disclosed herein. The enumeration of numeric ranges by threshold values includes all numbers and sub-totalized fractions in this range, as well as the threshold values enumerated. The term "% by weight" (percent by weight), herein and throughout the specification unless otherwise defined, refers to the relative weight of the component under consideration in relation to the overall weight of the formulation.
    In a first aspect, the present invention relates to a method based on collected data and an algorithm, whereby one or more Notation Factors are calculated, and whereby said Notation Factor is a measure of propensity to issue a response. painful stimulus or therapeutic strategy; and / or a measure of the intensity of said response.
    A response to pain or pain stimulus is strongly dependent on the subject and is a consequence of a plethora of factors, both in relation to the physiological causes and effects of painful stimuli as well as to factors intrinsically related to the subject's traits ( personality, health, environment, etc.). A method based on such a multifactorial approach using objectified algorithms has not yet been described.
    In addition, none of the currently known methodologies is able to provide a predictive view of pain and pain development, regardless of whether the subject is currently a pain patient or a healthy subject.
    For the purpose of the present invention, said Notation Factor is a measure of a certain characteristic analyzed (in this case the propensity for a subject to develop or test pain under given stimuli or under a given management treatment pain). The Notation Factor may be a numerical factor, as an indication of the analyzed characteristic based on a specific scale, whereby the higher the numerical factor is on the scale, the more likely the analyzed characteristic is to be present. For example, in the context of the present invention, said Notation Factor may provide a scale with respect to the propensity of a subject to be eligible to experience pain. In another embodiment, said Notation Factor may be a classification or categorization of the analyzed characteristic in a certain subclass. For example, in the context of the present invention, said Notation Factor may determine whether a subject is responder or nonresponsive to a painful stimulus or a pain management treatment ("yes" or "no"). In general, said Notation Factor is a (predictive) value (for example a color code, a definition, a term, a numerical factor, etc.) of the subject's response to a painful stimulus or a management treatment of the patient. pain or the natural course of the disease. In yet another embodiment, said Notation Factor may be a measure of the intensity of pain experienced by a patient, for example on a scale of 0 to 10, where 0 means no pain, 10 meaning maximum pain.
    In a preferred embodiment, one or more Notation Factors will be assigned to said subject, whereby said Notation Factor is a measure of the propensity to emit a response to pain and a measure of the intensity of the response. For this purpose, the data obtained are used in a mathematical model, the result of said model being the Notation Factor. As such, a Notation Factor is representative of the pain profile of a subject or a component of a subject's pain profile. Multiple Rating Factors may be calculated based on their intended future use.
    In the context of the present invention, the term "pain profile" should be understood as the subject's "result" or "response" to a painful stimulus or pain resulting from the progression of the pain. disease with or without the application of a treatment or pain management strategy, as expressed, perceived or measured by a subject to qualify or quantify both the improvement and the deterioration of pain experienced under a stimulus given or in the context of administering a given pain management treatment.
    As understood here, "Pain Profile", "Pain Footprint" or "Pain Signature" and "Pain Patterns" are synonymous.
    In the context of the present invention, the term "predictor" and any of its derivatives (predictive, prediction, ...) must be understood as providing a probabilistic image of an analyzed characteristic (in this context a profile pain), said image is preferably calculated according to a computer model. If not or in addition, predicting must be understood as anticipating the evolution of said characteristic in time or during a predefined period of time. The term "pain-related symptoms" should be understood as subjective changes noted or reported by the patient, for example pain caused by a specific movement such as walking or the temporal characteristics of painful seizures. Signs related to pain are objective findings that can be obtained by a clinician examining the patient, for example, signs of inflammation such as redness or swelling.
    In the context of the present invention, said pain stimulus or pain stimuli may be understood as any cause or origin of a painful sensation or observance in a subject, including for example pain caused by the disease.
    In the context of the present invention, said "response" is to be understood as the result perceived by a subject in response to stimuli or treatment given to said subject.
    Preferably, said response to a treatment or pain management strategy is favorable. A "favorable response" or "favorable clinical response" should be defined as a pain-relieving treatment referring to a physiological and / or psychological response of a subject recognized by professionals in the field indicating a decrease in intensity. expressed in comparison with the pain intensity that would be expressed by the subject under alternative treatment or in the absence of treatment.
    For example, an answer can be analyzed on the basis of interviews with the subject, a doctor's examination and / or pain tests. Such a favorable response may be a complete favorable response, i.e., showing an optimal improvement in all targeted aspects or symptoms (regression) or a mixed response, i.e. where the improvement is perceived on some but not all aspects or symptoms targeted.
    More specifically, said method comprises a sequence of steps, whereby in a first step the data is collected from a subject. In a second step, one or more combinations of the collected data are calculated, whereby said data comprises data of questions relating to personality and / or health and / or one or more (bio) physical tests and / or one or more several tests of social behavior in relation to pain performed by or on said subject. In a more preferred embodiment, said collected data includes any combination of two or three of the questions / tests mentioned above. In another more preferred embodiment, said data includes data obtained from all tests and questions mentioned above.
    In the context of the present invention, "line or features" should be understood as all kinds of variables, directly or indirectly related to a subject, which can be introduced into the model according to the present invention, and which are used to enter a or more Notation Factor. In more detail, said traits are identified by a professional on the basis of the present understanding of the different aspects potentially related to the pain, and routinely collected using questionnaires and / or existing tests. In a preferred embodiment, said line variables may be numerical or nominal.
    In the context of the present invention, "personality traits" should be understood as the characteristics of a subject relating to the psychology of the subject, the physical characteristics of the subject and / or the personal history information of that subject. Said characteristics of psychology may include, but not be limited to, emotional characteristics, behavioral characteristics, general beliefs of the subject and / or emotional traits. These personality questions are questions or sets of questions that gauge the personality traits of a subject.
    Said health traits may include any information relating to the health of a subject, as well as that of the family of the subject. Said health traits may for example include, but not be limited to, old and present diseases, treatments received, current and past use of drugs, potential health risks, genetic predisposition to develop a disease, etc. Said health questions are questions or sets of questions that gauge the health traits of a subject.
    In the context of the present invention, said social learning or social behavior can be understood as a process where subjects observe the behavior of others and its consequences, or specific situations and patterns to modify their own behavior accordingly. Said social learning test includes providing a subject with behavioral, environmental and / or exemplary information or stimuli, thereby eliciting (or not) a response from said subject, based on the information received.
    In various embodiments of the invention, the subject is a mammal, such as a human, a cat, a dog, a rodent, a primate, cattle, horses, etc. Preferably said subject is a human. More preferably, said subject is a patient, preferably a patient suffering from pain caused by the disease.
    Said pain may be due to a functional disease that may include chronic pain. An exemplary condition of chronic pain is neuropathic pain, which may include post-herpetic neuralgia, HIV neuralgia, diabetic neuropathy, Fabry disease, peripheral neuropathy, trigeminal neuralgia, neuropathic pain post-injury, pain phantom limb, reflex sympathetic dystrophy, causalgia, painful anesthesia, intercostal neuralgia, localized posttraumatic pain, complex regional pain syndrome, or neuropathic pain due to trauma, lead, or chemotherapy.
    By "acute pain" is meant short-term pain that resolves completely and follows direct stimuli such as trauma (eg resulting from acute injury or surgery), inflammation, or burns. Acute pain usually stops when the stimulus is removed or the injured tissue heals.
    By "acute pain stimulus" is meant a stimulus that causes acute pain in a subject. By "chronic pain" is meant persistent pain that is not due to an acute stimulus. More commonly, chronic pain is the result of a medical condition such as infection, arthritis, chronic injury (eg, sprain), cancer, migraine, irritable bowel disease, visceral pain (eg, chronic pancreatitis), and pain. neuropathic. Chronic pain can also be idiopathic, for example, fibromyalgia. Such pain may persist long after the triggering event.
    By "neuropathic pain" is meant pain due to injury to a peripheral nerve or central nervous system (e.g., stroke or spinal cord injury). Neuropathic pain may include, but is not limited to, burning sensation, hyperpathia, dysesthesia, allodynia, or phantom pain. Types of neuropathic pain include, for example, infectious pain (eg, post-herpetic neuralgia and HIV neuropathy), metabolic (eg, diabetic neuropathy and Fabry disease), toxic (eg, lead or chemotherapy), traumatic / stretching ( for example, post-incision, trauma, phantom limb pain, and reflex sympathetic dystrophy / regional pain syndrome complex / causalgia), and idiopathic (eg, trigeminal essential neuralgia).
    By "therapeutic intervention or pain management strategy or pain management treatment" is meant a protocol contemplated to have a preventive, beneficial, curative, or stabilizing effect. Examples of therapeutic interventions include pharmaceutical compositions, physical stimuli (e.g., massage or acupuncture), electrical stimuli, thermal stimuli, electromagnetic radiation, counseling, or surgical, medical, or dental procedures. The therapeutic intervention or pain treatment strategy may comprise a compound, a physical stimulus, an electrical stimulus, a thermal stimulus, electromagnetic radiation, counseling, or a surgical, medical, or dental procedure, or a combination thereof. this. The therapeutic intervention may also be administered less than the therapeutic amount. Examples of acute pain stimuli include temperature change, mechanical force, pin prick, or administration of a compound. The level of activation is measured, for example, by a neuroimaging apparatus, such as a functional magnetic resonance apparatus, a positron emission tomography (PET) apparatus, a magnetoencephalography (MEG) apparatus, a electroencephalographic (EEG) apparatus, a computer-assisted single photon emission computed tomography (SPECT) apparatus, an infrared (IR) apparatus, a diffuse optical tomography (DOT) apparatus, a magnetic resonance spectroscopy apparatus ( MRS), or a computer-assisted functional tomography (CT) device. When a control is used, the same subject can both be tested by the methods described herein and serve as a control. The level of activation can be measured in one or more CNS regions, eg, orbitofrontal cortex (Gob), ventral tegmentum / VT / PAG peri-aqueductal gray matter, nucleus accumbens (NAc), enlarged sublenticular amygdala (SLEA), cingulate gyrus , primary somatosensory cortex (S24), secondary somatosensory cortex (S2), thalamus, insula, cerebellum, prefrontal cortex, amygdala, hypothalamus, parahippocampal gyrus, hippocampus, entorhinal cortex, ventral pallidum, dorsal striatum, primary motor cortex ( M24), secondary motor cortex (M2), additional motor cortex (SMA), frontal ocular area (FEF), ventromedial rostral medulla (RVM), cerebellum, lateral prefrontal cortex, middle frontal gyrus (Brodmann areas 44, 45, 46, 47), superior frontal gyrus (Brodmann areas 6, 8), or sub-nuclei of the brainstem. In addition, the activation level is not measured with reference to specific regions of the CNS.
    There are many independent questionnaires and pain tests available on the market, but to date none of them have been combined correctly to infer a profile of the pain. Questionnaires known today (eg, Brief Pain Inventory, McGill Pain Questionnaire, Memorial Pain assessment, etc.) are not predictive and each of these questionnaires taken separately means (by those who created them) to provide a self- autonomous assessment of pain. In addition, today's biophysical / somatosensory tests (eg mechanical pain threshold, vibrational defects, etc.) are based on a quantitative sensory test (QST) primarily assessing nociceptive pain and the neuropathic component of pain.
    A simple juxtaposition of these known tests is not feasible, in that the latter will not produce a sufficient profile and will constitute a burden too heavy for the subject (due to too long test for example).
    The methodology proposed by the present invention allows a very fast analysis of a subject, to obtain information on the pain profile of a subject in a minimum of time. This makes it possible to carry out the test several times, even in a very short period of time (for example less than 24 hours, a week, etc.).
    In the context of the present invention, said (bio) physical test must be understood as any test, in connection with the measurement or detection of a biophysical parameter. For example, said (bio) physical test may include but not be limited to measuring or analyzing a biological compound of said subject; measuring or detecting a biological reaction of said subject; performing a neurological test on said subject; measuring or sensing a sensory reaction; to perform a tactile test on said subject.
    Preferably, said (bio) physical test involves a neurological, somatosensory, tactile or analytical test, or a combination thereof.
    In a preferred embodiment, said (bio) physical test takes into account changes in the somatosensory system. Some tests include QST and other tests that may include controlling heart rate, controlling blood pressure, controlling breathing, measuring one or more blood components or metabolites (eg blood chemistry), or other biological fluid, to measure cutaneous parameters such as blood flow, temperature, or skin conduction; or other physiological measures including measuring any brain or neurological activity, resonance cutaneous conduction (SCR), electroencephalography (EEG), quantitative EEG (QEEG), magnetic resonance imaging (MRI), functional MRI, (fMRI), CT-assisted tomography computer (CT), positron emission tomography (PET), electronystagmography (ENG), computer-assisted mono-photonic emission tomography (SPECT), magnetoencephalography (MEG), superconducting quantum interference device (SQUIDS), electromyography, morphometric scanning cutaneous surfaces, eye tracking, and / or pupillary diameter change, pain tests such as thermal pain procedure.
    Preferably, said (bio) physical test comprises a pain test or a pain score test. Said test may be based on sensations or physical impressions such as thermal stimuli, tactile stimuli for example by van Frey monofilaments, by brush stroke, by a needle, by a pin prick, by the cold, by vibrations for example applied to the skin.
    The method of the present invention involves questioning a subject about health and / or personality issues. For the latter, specific personality queries are elaborated, said personality queries include questions selected from sets of questions or combinations of questions from different sets.
    These sets of questions can be divided into the following groups or aspects.
    In one embodiment, said personality survey includes one or more selected questions from sets of questions for characterizing traits or personality characteristics of a subject that are stable over time and attributable to the person and are not the effect of his environment. Said set of personality-related questions includes one or more questions to measure expectations, optimism, source of. determination, anxiety, rehash, confusion, all well known to the professional of the field.
    In another embodiment, the survey includes one or more questions selected from question sets for measuring or evaluating the impact of a subject's environment on his or her perception of health issues.
    The set of questions related to the impact of the environment includes: - one or more questions to measure the impact of the behavior (pleasant, open, severe ...) or the intervention (oral, acts ...) the caregiver; - one or more questions to assess the level of anxiety, fear, discouragement, depression related to the environment of a clinical setting or a caregiver.
    In another embodiment, said survey includes one or more questions selected from sets of questions for assessing the impact of a subject's psychological quality of life, satisfaction, stress resistance, and resistance to stress. the Depression...
    In another embodiment, the survey includes one or more questions selected from sets of questions to evaluate the response to a subject's attitudes or emotions to external stimuli. The set of questions includes questions to measure the level of control the subject believes he has over his life, the level of mastery of external factors or health-related symptoms of his life such as luck, fate, life events, or other strong influences (such as parents, health professionals, co-workers etc.) and to measure the level of control of other strong influences such as parents on their attitude to resist, combat or overcome aggressive external factors or symptoms related to health.
    In yet another embodiment, said set of questions may include one or more questions to assess the extent to which the caregiver believes that health-related symptoms influence the overall physical and psychological condition of a patient including the functioning of his or her health. organization, activity, mobility, work capacity, relationships with others, sleep, life satisfaction, mood, ... and the influence of health-related symptoms on its general state evolves with time.
    In another embodiment, the survey includes one or more questions selected from sets of questions to assess the degree (intensity) of the pain. The set of questions includes one or more questions to measure: - how much the subject feels that said pain influences his general physical and psychological condition including the functioning of his body, his activity, his mobility, his work capacity, his relations with others, his sleep, his satisfaction with life, his mood, ... and how the influence of pain on his general condition changes over time. - to what extent the caregiver considers that the said pain influences the general physical and psychological state of a patient including the functioning of his organism, his activity, his mobility, his capacity for work, his relationships with others, his sleep, his satisfaction with regard to life, his mood, ... and to what extent the influence of the said pain on his general state evolves with time.
    In another embodiment, said survey includes one or more questions selected from sets of questions to characterize the typology and location of the pain. The said set of questions includes one or more questions to define: - the painful areas, - how the subject translates the pain into terms and qualifications such as pain due to cold, burning, electric shocks, mechanical shocks, tingling, tingling, numbness, itching etc. - the physical state of the painful area such as hypoesthesia to the touch, hypoesthesia to the sting, pain due or increased during mechanical actions on the body such as brushing, pinching etc.
    In another embodiment, said survey includes one or more selected questions in any of the sets of questions described above. The sets described above may be in the form of questionnaires known in the art (eg source of determination, etc.) or may include questionnaires that are specifically designed by the inventors of the present invention.
    A Notation Factor in relation to the pain profile will preferably be calculated by a mathematical function on the input data. This model will be constructed on the basis of the input data, the effect of the Notation Factor can then be calculated for each tested subject. Preferably, said model will be predictive. In one embodiment, said mathematical model will use Bayesian principles. In another embodiment, any other appropriate mathematical model known to those skilled in the art can be used in the present invention. In a more preferred embodiment, said model is implemented by computer processing.
    Figure 1 shows a schematic overview of an embodiment of the methodology according to the present invention.
    Let P be a population defined according to an X matrix of n rows and p columns of input data and Y a vector of size n corresponding to the observed responses. Each of the n lines of X corresponds to a patient. Each of the p columns of X corresponds to a trait, that is to say a personality trait. A signature S is defined as a subset of the input p traits. S is of size p 'less than or equal to p. S is used to define a new matrix called X 'of n rows and p' columns which with Y defines P '.
    An estimation model occurs on P '. The resulting model is called Μ. M is a function that maps a vector x of size p 'to an output y. This output is a component of the evolution of the pain profile, the Notation factor in the case of the present invention.
    FEATURES
    The p-lines constituting the X-matrix columns described here were identified by a domain professional based on the current understanding of the various aspects potentially related to pain, and commonly collected using questionnaires and / or tests. existing. A professional in the field will understand that traits captured during such tests and / or surveys may be captured in other, but similar, surveys or tests. The same traits but formulated in a different way to that described here entered during surveys and / or tests can thus be used in X as well rather than restrict the definition of X to the questionnaires and / or tests described above.
    TYPE OF PREDICTION
    In one embodiment, entries of the vector Y are binary variables corresponding to the responders and non-responsive to a pain stimulus or a treatment / or pain management strategy respectively.
    In another embodiment, entries of the vector Y are ordinal variables with a finite number of modes corresponding to different levels of response (e.g., non-responders, low responders, slightly responders, high responders) to a painful stimulus or treatment / or pain management strategy.
    In another embodiment, Y inputs are continuous variables corresponding to either the response probability or the response intensity with respect to a pain stimulus or a pain management treatment / strategy.
    In another embodiment, entries of the vector y are nominal variables with a finite number of modes corresponding to the different forms of responses to a pain stimulus or a treatment / or pain management strategy.
    MODEL
    In one embodiment, the M model is in the form of a linear regression or classification model.
    In another embodiment, the model M has the form of a search method of the Nearest Neighbor.
    In yet another embodiment, the model M is in the form of a decision tree.
    In another embodiment, the model M is a set of models according to the forms defined above constructed from various subsamples of the columns and or lines of P '.
    Otherwise, classification or regression can be performed using other mathematical methods well known in the art.
    In all cases, the compromise sensitivity and specificity of the models can be set via a meta parameter according to the application context. The present invention covers all possible compromises.
    As described herein, methods for predicting a response to a pain stimulus or a pain management treatment / strategy or for identifying subjects most likely to respond to a pain stimulus or a treatment / treatment. a pain management strategy, does not mean to pretend to a 100% predictive capacity, but indicate whether subjects with certain traits are more likely to experience a response to a painful stimulus or treatment / or pain management strategy than subjects to whom such features are lacking. However, as will become apparent to a professional in the field, some subjects identified as being more likely to experience a response may still fail to describe a response to a painful stimulus or a measurable pain management treatment / strategy. . Similarly, some predicted non-responder subjects may nonetheless respond to a painful stimulus or a pain management treatment / strategy.
    Preferably, the allocation of the Notation Factor is implemented by computer processing. The latter allows a fast and reliable analysis of input data. In one embodiment, said allocation can be made in a location remote from the data collection site. Said data may be obtained at a specific site and transferred to a second site (e.g., electronically, computer cloud storage systems, etc.), where data analysis and Rating Factor assignment take place.
    In the context of the present invention, the terms "predictive" and any of its derivatives (predictive, prediction ...) must be understood as providing a probabilistic image of an analyzed characteristic, said image is preferably calculated according to A model. If not or in addition, predicting must be understood as anticipating the evolution of said characteristic in time or during a predefined period of time.
    Thus, the present invention also relates to a computer processing method for predicting the evolution of the pain profile in a subject. Preferably, said computer processing method comprises: (a) capturing data obtained from personality and health related surveys, social learning and / or (bio) physical tests performed by a subject; (b) calculating a propensity measure to respond to a pain stimulus or a pain management treatment / strategy.
    In addition, the present invention also relates to a computer program product. The computer program product includes at least one computer-readable storage medium having computer-readable stored program code portions, the computer-readable program code portions comprising instructions for calculating a Notation Factor for a subject, said Notation Factor is related to said subject and is a measure of propensity for said subject to respond to a painful stimulus or therapeutic strategy; and / or is a measure of the intensity of said response of said subject, whereby said Notation Factor is based on subject-specific data obtained from personality and / or health-related surveys, and from pain-related (bio) physical tests performed by and on said subject.
    A schematic representation of a possible embodiment of a computer interface according to the present invention is shown in FIG.
    In another embodiment, the input data for said subject, such as the Notation Factors thereof, may be stored in a database; said database can be stored on an external server. Such a database can be used for further analysis and refinement of the algorithms and queries used to determine said Notation Factor. In another embodiment, survey or queries are also stored on an external server. The latter allows third parties to make use of the methodology and the system, for example by connecting remotely to the system. In another more preferred embodiment, said database and queries are eligible for cloud computing ('computing cloud') and storage and / or computing in the cloud.
    In a preferred embodiment, the Notation Factor obtained and possibly the imputed test and / or the survey results will be summarized in a report, said report may be a numerical report sent to the person making use of the methodology. Temporal dependence
    Not only is the pain profile specific to the subject, but it can also change during an illness and / or treatment. The rating of the intensity of the pain (or (self) evaluation of the pain) is also not constant over time in a specific patient. Pain scores and therefore Rating Factors may vary over time depending on the evolution of the subject's personality traits and health traits as well as with the subject / patient's proposed pain management program. This raises other concerns to know when conducting clinical trials where the evaluation of a new pain therapy will not necessarily be the same, for a subject / patient, at the beginning of the clinical trial or any throughout his execution. Thus, to conduct clinical trials for any therapeutic indication where effective pain management is assessed, there is a need for regular reassessment of the pain response of subjects included in the clinical trial (both in groups). experimental and control of the study). Therefore, such a profile of the pain would not represent an additional burden for both the patient and the caregiver. Due to the ease of the method described in the present invention, the method is adapted to define Notation Factors for a subject over a period of time (predefined), for example during a treatment or a clinical trial. Said plurality may be widely understood, and may encompass several times a day (eg 2, 3, 4 times) or several times a week, a month, a year for a period (predefined). Said time interval may for example be the duration of a specific treatment or the duration of a clinical trial, or the duration of a disease (for example from diagnosis to cure), or throughout the life of said subject . As a result, multiple Notation Factors for a subject can be produced during a time interval.
    The Notation Factors produced may be used as a measure, for example, of the subject's propensity to develop a response to a pain stimulus and / or a pain management treatment. Said response to a painful stimulus should be understood as a physiological and / or psychological reaction of a subject subject to a stimulus known to cause pain or at least a component of the pain. The said component of the pain may be sensory, biological or psychological.
    Improved pain management strategies
    The method of the present invention is specifically useful for predicting a profile of a subject's pain or for predicting a subject's propensity to respond to pain management treatment. Thus, by practicing the present invention, the treatment of a patient's pain can be optimized, unnecessary treatments can be avoided, and undesirable effects can be minimized. The present invention therefore also relates to a method for identifying subjects for a therapeutic treatment based on their propensity to respond favorably to a pain management treatment, thereby predicting a Notation Factor according to the method described above.
    A pain management treatment should be understood as a detailed and personalized treatment adapted to the needs of the subject for which one or more Pain Profile Rating Factors have been determined according to the method of the present invention. The strategy may include one or more drug treatments (e.g., drug type, combination of various drugs, duration of drug treatment, treatment protocols, dosage, mode of administration) as well as non-drug treatments. The said non-medicinal treatments may include physical treatments such as physiotherapy, massage, transcutaneous electrical nerve stimulation (TENS), etc. ; and / or complementary treatments such as relaxation, yoga, acupuncture, aromatherapy, etc. In a more preferred embodiment, said pain management treatment comprises both drug and non-drug treatments.
    Preferably, said response to a pain management treatment is favorable. By performing the method according to the present invention, new treatments for pain relief for pain-causing diseases or functional diseases can be proposed as specific treatment plans for the patient. In addition, existing pain relief treatments can be optimized.
    As a corollary, the present invention will also provide the treating physician a patient with a proposal for a new or improved therapy or treatment. To date, most of the linear treatment plans are known and used whereby, for example, a standard treatment plan is used for each patient suffering from pain due for example to a specific disease. WHO, for example, recommends the use of a "pain scale" for the evaluation of cancer pain, based on analgesic treatment. In the field of focal neuropathic pain, conventional pain management is based on the first-line use of lidocaine, antidepressant and antiepileptic compounds, while second-line skin capsaicin, tramadol and opiates. The success rate of such linear therapy is often variable and disappointing, the latter not taking into account non-uniform reactions to pain and pain treatment. The present method aims to provide an alternative to these linear treatments, for example by suggesting other modes of administration and / or the use of co-therapies, etc.
    The development and evaluation of new analgesic drugs will also be facilitated by calculating one or more Notation Factors according to the present invention. In addition, the design of clinical trials can be improved by allowing the investigation of the effects of drugs on the specific mechanisms of pain, rather than trying to measure the overall reduction of pain.
    Improved Clinical Trial Designs
    In another aspect, the method of the present invention can also be used to select participants in a clinical trial. As used herein "a clinical trial" or "a clinical study" should be understood as relating to all types of health-related studies for which data on safety and efficacy is a prerequisite. As such, said trial or clinical study may refer to any research study, such as a biomedical or health research study, designed to obtain data on safety or efficacy of a therapeutic treatment such as a drug, a device, or a treatment. The said trial or clinical study may also relate to epidemiological or observational studies, market studies and surveys. Evaluation of the Notation Factors of the present invention will provide tools for selecting and studying patient populations with specific pain profiles. Optionally, the present invention can radically change the design of pharmacological tests for the study of the specific effects of drugs on the mechanisms of pain. Likewise, it will have a significant impact on the design of investigations involving the significance of known mode of action of drugs as well as on changes in the indication for the use of specific analgesics determined on the label or package leaflet, authorized by regulatory agencies such as the Food and Drug Administration (FDA) or the European Agency for the Evaluation of Medicinal Products (EMEA).
    The production of subject-specific pain profiles taking into account all relevant variables for the detection or the pain experience will improve the transfer of knowledge about the efficacy of compounds derived from animal models to the clinical application as it provides a method to design drug trials based on a specific experience of pain. Patients may be included in trials only if they have a particular profile that may for example be linked to a particular target of the action of a drug. As a consequence of a better selection methodology, the sample size required for the clinical trial can be considerably reduced by the method of the present invention. In addition, such optimized selection of sample size will result in faster and more reliable testing decisions, which will have a positive impact on ethical issues related to clinical trials and patient exposure to clinical trials. experimental compounds.
    Additional diagnostic tools
    In another aspect, the present invention also relates to a complementary diagnostic tool. The complementary diagnostic tool should be understood as a tool to predict whether a patient will respond to a certain pain management treatment. In one embodiment, said complementary diagnostic tool according to the present invention is a complementary diagnostic tool for predicting the response of a subject undergoing a pain management strategy. The tool preferably includes instructions for calculating one or more Notation Factors for said subject, whereby said Notation Factor is a measure of propensity to respond to painful stimulus or pain management treatment based on data. Subject-specific subjects obtained from personality traits and / or health-related traits and / or social learning tests and / or one or more (bio) physical tests performed by or on the subject.
    This will improve patient outcomes and lower healthcare costs. For patients with some pain or pain-causing illness, those identified as "not likely to meet a certain pain management strategy" can quickly move on to others - perhaps more effective - treatments if they exist.
    In addition, the complementary diagnostic tool of the present invention helps the health system to reduce costs by identifying the patient population that is more likely to benefit from treatment, and to exclude treatments that are not likely to be effective. This is particularly important as some high-priced therapies (eg for cancer) enter the market. An additional benefit can be achieved by lowering costs related to the management of adverse effects or hospitalizations due to unnecessary treatments.
    In another aspect, the present invention relates to the use of the complementary diagnostic tool as described above for specific patient treatment or for stratification of subjects for clinical trial for a specific treatment.
    As noted above, the tool can be used to decide on the optimal treatment of a patient. Second, the tool can also be used to classify / stratify subjects involved in a specific clinical trial or treatment. Before being engaged in a clinical trial, the pain profile of an engaged subject can first be assessed, after which it can be decided in which group the subject can be categorized.
    In another embodiment, said complementary diagnostic tool will be useful as a tool for predicting whether or not, during a treatment or a trial, the result of the test is biased or not due to the evolution over time of the pain profile of the subjects involved (change / drift of the pain profile). The tool according to the present invention is fast and reliable, can be used several times throughout the test and is adapted to qualify and / or quantify a profile of the pain.
    Finally, the present invention also relates to a set of questions or surveys, or a combination thereof, used either in a method as described above, or in a complementary diagnostic tool as explained above.
    Although the exemplary embodiments of the present invention have been described in great detail, it should be understood that the invention is not limited to these embodiments. Various changes or modifications may be made by a professional in the field without departing from the purpose or spirit of the invention as defined in the claims.
    权利要求:
    Claims (14)
    [1]
    A method, said method comprises collecting data by interrogating a subject on personality and / or health traits; and / or - performing one and / or several (bio) physical tests by or on said subject; characterized in that said data is a set of mathematical models thus assigning one or more Notation Factors to said subject, whereby said Notation Factor is a measure of the propensity of said subject to emit a response to a pain stimulus or a therapeutic strategy ; and / or measuring the intensity of said response of said subject.
    [2]
    2. Method according to claim 1, characterized in that said Notation Factor is calculated by means of a mathematical model.
    [3]
    3. Method according to any one of the preceding claims characterized in that said model is implemented by computer processing.
    [4]
    4. Method according to any one of the preceding claims, characterized in that said personality survey comprises questions selected from sets of questions or combinations of questions from different sets, said sets of questions: - relate to personality traits of a subject; - measure or evaluate the impact of a subject's environment on health and / or psychological problems; - evaluate the impact of the quality of life of a subject; - measure the expectations of a subject, evaluate a response on the attitudes or emotions of a subject; - assess the extent to which the health worker believes that health-related symptoms influence the general physical and psychological state of a patient; - measure or evaluate the level of pain; - characterize the typology and location of pain; and - evaluate the level of symptoms related to the health of said subject.
    [5]
    5. Method according to any one of the preceding claims, characterized in that said multiple Notation Factors for a subject are produced during a time interval.
    [6]
    A computer processing product, said computer program product comprises at least one computer readable storage medium having computer readable program stored code portions, the computer readable program code portions comprising instructions for calculating a Factor of Notation for a subject, said Notation Factor is related to said subject and is a measure of propensity for said subject to respond to a painful stimulus or a therapeutic strategy; and / or measuring the intensity of said response of said subject, whereby said Notation Factor is based on subject-specific data obtained from personality and / or health surveys, and / or (bio) physical tests related to pain performed by or on said subject.
    [7]
    A method for predicting the probability of a subject's response to a painful stimulus, the method comprising assigning one or more Notation Factors to a subject according to any one of claims 1 to 5.
    [8]
    A method for predicting the response of a subject to a pain management treatment or for predicting progression and / or outcome of pain, the method comprising assigning one or more Rating Factors subject according to any one of claims 1 to 5.
    [9]
    9. A method for predicting a response of a subject to pain management treatment according to claim 8, characterized in that said response is favorable.
    [10]
    A method for developing new therapies or for optimizing existing pain relief treatments, the method comprising assigning one or more Notation Factors to a subject according to any one of claims 1 to 5.
    [11]
    11. The method of claim 10, characterized in that said treatment comprises drug and / or non-drug treatments.
    [12]
    12. A complementary diagnostic tool, said tool includes instructions for calculating one or more Notation Factors for a subject, said Notation Factor is related to said subject and is a measure of propensity for said subject to respond to a painful stimulus or a therapeutic strategy; and / or measuring the intensity of said response in said subject, whereby said Notation Factor is based on subject-specific data, said subject-specific data is obtained from personality surveys and / or relating to health and / or one or more pain-related (bio) physical tests performed by or on said subject.
    [13]
    13. Use of a diagnostic complementary tool according to claim 12 for providing a patient specific pain relief treatment, for diagnosing and / or predicting a response, for predicting the course and outcome of pain.
    [14]
    14. A set of questions or queries or combinations thereof for use in a method according to any one of claims 1 to 5 or for use as a complementary diagnostic tool according to claim 12.
    类似技术:
    公开号 | 公开日 | 专利标题
    De Pablo-Fernandez et al.2017|Association of autonomic dysfunction with disease progression and survival in Parkinson disease
    Paulus et al.2005|Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse
    Biffi et al.2016|Risk factors associated with early vs delayed dementia after intracerebral hemorrhage
    Hauser et al.2014|Role of the medial prefrontal cortex in impaired decision making in juvenile attention-deficit/hyperactivity disorder
    Kim-Cohen et al.2003|Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort
    Lidstone et al.2010|Effects of expectation on placebo-induced dopamine release in Parkinson disease
    Pandian et al.2004|Digital video-electroencephalographic monitoring in the neurological-neurosurgical intensive care unit: clinical features and outcome
    Gotlib et al.2010|Neural processing of reward and loss in girls at risk for major depression
    Kuntsi et al.2010|Separation of cognitive impairments in attention-deficit/hyperactivity disorder into 2 familial factors
    Munson et al.2006|Amygdalar volume and behavioral development in autism
    Lo et al.2009|Clinical features in early Parkinson disease and survival
    Payer et al.2011|Neural correlates of affect processing and aggression in methamphetamine dependence
    Crespo-Facorro et al.2001|Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors
    Teipel et al.2002|Progression of corpus callosum atrophy in Alzheimer disease
    Buchman et al.2009|Association between late-life social activity and motor decline in older adults
    Butler et al.2005|Early-stage visual processing and cortical amplification deficits in schizophrenia
    Doniger et al.2002|Impaired visual object recognition and dorsal/ventral stream interaction in schizophrenia
    Thomas et al.2001|Amygdala response to fearful faces in anxious and depressed children
    Cilia et al.2008|Functional abnormalities underlying pathological gambling in Parkinson disease
    Stunnenberg et al.2018|Effect of mexiletine on muscle stiffness in patients with nondystrophic myotonia evaluated using aggregated N-of-1 trials
    Burt et al.2010|Does marriage inhibit antisocial behavior?: An examination of selection vs causation via a longitudinal twin design
    Day et al.2013|Salience network resting-state activity: prediction of frontotemporal dementia progression
    Watson et al.2008|Aberrant brain activation during gaze processing in boys with fragile X syndrome
    Graff-Radford et al.2017|Duration and pathologic correlates of Lewy body disease
    Ross et al.2004|Disability and chronic fatigue syndrome: a focus on function
    同族专利:
    公开号 | 公开日
    EP2987451A1|2016-02-24|
    BE1023314A1|2017-02-01|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    JP3319318B2|1997-01-31|2002-08-26|スズキ株式会社|Outboard exhaust system|
    US5908383A|1997-09-17|1999-06-01|Brynjestad; Ulf|Knowledge-based expert interactive system for pain|
    US20030097185A1|2000-12-29|2003-05-22|Goetzke Gary A.|Chronic pain patient medical resources forecaster|
    US20030233053A1|2002-06-14|2003-12-18|Woolf Clifford J.|Pain assessment|
    US7097617B1|2004-03-31|2006-08-29|Wallace Lynn Smith|Method for diagnosis of pain relief probability through medical treatment|
    WO2006039416A2|2004-10-01|2006-04-13|The Mclean Hospital Corporation|Cns assay for prediction of therapeutic efficacy for neuropathic pain and other functional illnesses|
    US8574156B2|2005-07-05|2013-11-05|General Electric Company|Determination of the clinical state of a subject|
    US20140221181A1|2011-08-26|2014-08-07|Luke Pickett|Exercise and wellness monitoring method and system|
    EP3483288B1|2011-11-30|2022-03-16|Children's Hospital Medical Center|Personalized pain management and anesthesia: preemptive risk identification|
    US20130217976A1|2012-02-22|2013-08-22|B. Todd Heniford|Method for Predicting Quality of Life After Medical and Surgical Treatment|
    US20150248843A1|2012-10-12|2015-09-03|Analgesic Solutions|Training methods for improved assaying of pain in clinical trial subjects|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    EP14181316.2|2014-08-18|
    EP14181316.2A|EP2987451A1|2014-08-18|2014-08-18|Method and tools for predicting a pain response in a subject|
    [返回顶部]